Inc.;Dana-Farber Cancer Institute;AbbVie Biotherapeutics Inc.;Dana-Farber Cancer Institute, Inc.
发明人:
Anderson, Kenneth C.,Afar, Daniel,Tai, Yu-Tzu
申请号：
AU2007281684
公开号：
AU2007281684C1
申请日:
2007.08.07
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprisinga therapeutically effective amount of HuLuc63, a therapeutically effectiveamount of lenalidomide and/or bortezomib, and a pharmaceutically acceptablecarrier, wherein said composition is capable of beeing administered in a singleor multiple dose regimen.
